Europe lifts warning on Pfizer smoking cessation drug

LONDON (Reuters) - European regulators have lifted a warning on Pfizer's smoking cessation drug Champix - called Chantix in the United States - after a clinical study concluded it did not appear to increase the risk of neuropsychiatric side effects.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news